-
Crisaborole
Jeneng API Indikasi Inovator Tanggal kadaluwarsa paten (AS) Crisaborole Dermatitis Atopik lan Eksim Pfizer -
Etelcacetide
Jeneng API Indikasi Inovator Tanggal kadaluwarsa paten (AS) Etelcacetide Hiperparatiroidisme sekunder (HPT) Amgen -
Abemaciclib
Jeneng API Indikasi Inovator Tanggal kadaluwarsa paten (AS) Abemaciclib Kanker payudara, perawatan kanker prostat Eli Lily 15 Desember 2029 -
Deucracitinib
Jeneng API Indikasi Inovator Tanggal kadaluwarsa paten (AS) Deucracitinib Psoriasis anti plak Perusahaan Bristol-Myers Squibb Nopember 07, 2033 -
Apremilast
Jeneng API Indikasi Inovator Tanggal kadaluwarsa paten (AS) Apremilast psoriatik atritis Celgene -
Remdesivir
Jeneng API Indikasi Inovator Tanggal kadaluwarsa paten (AS) Remdesivir Antivirus (Ebola, Covid-19) Gilead -
Pomalidomide
Jeneng API Indikasi Inovator Tanggal kadaluwarsa paten (AS) Pomalidomide Obat onkologi Celgene -
Nirmatrelvir
Jeneng API Indikasi Inovator Tanggal kadaluwarsa paten (AS) Nirmatrelvir 3C-Like Protease (3CLPRO) Inhibitor Lan SARS-Cov-2 Mpro Inhibitor -
Eltrombopag
Jeneng API Indikasi Inovator Tanggal kadaluwarsa paten (AS) Eltrombopag ITP & Anemia Aplastik Novartis & GSK Mei. 20, 2023 -
Ruxolitinib
Jeneng API Indikasi Inovator Tanggal kadaluwarsa paten (AS) Ruxolitinib Myelofibrosis Novartis 6 Juli 2024 -
Crisaborole
Jeneng API Indikasi Inovator Tanggal kadaluwarsa paten (AS) Crisaborole Dermatitis atopik lan eksema Pfizer 11 Juni 2026